Covid resurgence brings back Remdesivir, Tosi in demand – ET HealthWorld
Nagpur: Covid cases have almost touched the 300-mark in the fourth wave. With increase in number of hospitalizations and some…
Fast News Hear
Nagpur: Covid cases have almost touched the 300-mark in the fourth wave. With increase in number of hospitalizations and some…
New Delhi: The Supreme Court on Friday sought the Centre’s view on a PIL seeking to make pharma companies criminally…
Drug maker Cipla said it isn’t seeing much demand for drugs such as remdesivir, tocilizumab, favipiravir and certain inhaled corticosteroids…
With the continuous rise in Omicron cases of Covid-19, patients are looking at various drug options to relieve some symptoms….
HYDERABAD: The World Health Organisation (WHO)’s guideline development group of international experts has strongly recommended the use of rheumatoid arthritis…
The Centre on Friday said Remdesivir drug should only be used in patients with ‘moderate to severe’ COVID-19 and those…
Centre said Remdesivir drug should only be used in patients with ‘moderate to severe’ Covid New Delhi: The Centre on…
By Emilio Parodi MILAN, – The EU drug regulator will not decide whether to approve Merck & Co’s COVID-19 pill…
NEW DELHI: Two in five Indians who were treated for Covid-19 during the second wave has to pay a bribe,…
by Sanjay Vyas It’s no longer news that the COVID19 pandemic caught the world by surprise. While lockdowns ensued in…